SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

MM8 Medallion Metals Limited

Basic Materials · Other Precious Metals & Mining · website
$0.52
52wk 0.33 – 0.60
Overall
45.1
Value
71.5
Growth
0.0
Health
69.2
Quality
0.0
Momentum
83.0
Dividend
—
Price
About Medallion Metals Limited

Medallion Metals Limited engages in mineral exploration activities in Australia. It primarily explores for gold, silver, copper, lead deposits. The company's flagship property is the 100% owned Ravensthorpe gold project covering an area of approximately 600 square kilometers located in Perth, Western Australia. Medallion Metals Limited was incorporated in 2015 and is based in West Perth, Australia.

Commodity exposure

Primary exposure: Gold (detected from the company profile: gold)

Gold primary
4,213.80 USD/oz
1m: -3.5% · 1y: 9.7%
Copper
6.58 USD/lb
1m: 1.3% · 1y: 34.4%
Silver
61.52 USD/oz
1m: -4.9% · 1y: 33.7%
Price analytics

Returns

1 day -2.8%
1 week -5.5%
1 month -4.6%
3 months 19.8%
6 months 15.7%
1 year -8.8%
3 years 657.4%

Risk

Volatility (1y ann.) 73.0%
Beta vs ASX 200 2.54
Sharpe (1y) 0.18
VaR 95% (1-day) -6.7%
Max drawdown (1y) -44.1%
Off 1-year high -12.7%

Technicals

RSI(14) 46
vs 50DMA 0.6%
vs 200DMA 14.4%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 71.5
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
48
Price / Sales
0
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 83.0
6-month return vs ASX 200
100
Price vs 200-day average
98
Price vs 50-day average
53
Position in 52-week range
68

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$478.06M
P/E (trailing)
—
P/E (forward)
2.46
EPS (trailing)
-0.03
Dividend yield
—
Payout ratio
0.0%
Beta
0.24
EV / EBITDA
-22.43
Price / Book
4.56
ROE
-33.7%
Operating margin
-858.9%
Net margin
0.0%
Total cash
$53.89M
Total debt
$389,851
Current ratio
9.75
Debt / Equity
0.00
Free cash flow
$-22.23M
Avg volume
1.11M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$1.11M
  • Gross profit$1.11M
  • Operating income-$5.95M
  • Net income-$6.13M
  • Diluted EPS-0.01
  • Free cash flow-$9.54M
  • Net debt-$6.55M
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6